QA: Scynexis INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178253_2023_Scynexis_INC.pdf

Logs

Graph

Absolute values for 0001178253, Scynexis INC

  xvar xval
0 AssetsCurrent 79,061,000
1 IntangibleAssetsNetIncludingGoodwill 408,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 8,341,000
4 LiabilitiesCurrent 17,618,000
5 LiabilitiesNoncurrent 2,921,000
6 remainder_Liabilities 64,038,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 73,785,156
9 ResearchAndDevelopmentExpense 27,841,582
10 remainder_Expenses -3,474,512
11 remainder_Revenues 7,975,254
12 remainder_NetIncome 19,793,130
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 87,810,000
1 Liabilities 84,577,000
2 Expenses 98,152,226
3 Revenues 7,975,254
4 StockholdersEquity 3,233,000
5 NetIncome -70,383,842
6 ComprehensiveNetIncome -70,383,842
7 BaseVar 149,153,805
8 EconomicCapitalRatiobeforeLimitedLiability -0.735
9 EconomicCapitalRatio 1.35

Edgar->Model Mapping

Feature Distribution

Change over Time